Human monoclonal antibodies targeting rabies glycoprotein have been proposed as a potential alternative to rabies immunoglobulin to neutralise rabies virus at the wound site until sufficient virus ...

The RESONATE-2 trial reveals ibrutinib's long-term efficacy and safety in treating CLL/SLL, especially for high-risk patients ...

First, data and digital business services company, has been recognised as a Major Contender in Everest Group’s Life Sciences Digital Services PEAK Matrix® Assessment 2025. This recognition reflects ...

In this week’s edition of InnovationRx, we look at a biotech entrepreneur treating a rare genetic disease, new tech aimed at ...

Today’s Forbes CFO newsletter focuses on Aradhana Sarin’s journey from treating patients to becoming what she calls a ...

NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company transforming clinical trials today ...

An estimated 1·6 million adolescents (aged 10–19 years) were living with HIV in 2024, with adolescents having lower rates of ...

EVERSANA – which is pharmaphorum's parent company – said that The AI Agency has been set up in collaboration with Google and draws on the tech giant's validated, compliant, and powerful AI, including ...

Humans are inherently pattern-seeking creatures. Our ancestors depended upon recognizing recurring patterns in nature to ...

Dealmaking is in style again under President Donald Trump. Potential takeover targets include C3.ai, Viking Therapeutics, and ...

China's systemic integration, America's AGI ambition, Russia's security focus, Taiwan's hardware leadership, South Korea's ...